Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC PKSI-527 hydrochloride | 128837-71-8 | MFCD01745772 | 98.1% | 473.99 g·mol⁻¹ | C25H32ClN3O4 | 50MG
SDP

Supplier:  Medchemexpress LLC HY12313350MG

Encompass_Preferred

PKSI-527 is a selective small-molecule plasma kallikrein inhibitor used in preclinical research to investigate the kallikrein-kinin pathway and inflammatory disease models such as collagen-induced arthritis. It is supplied as a characterized hydrochloride salt at high purity for laboratory use only and is intended for in vitro and in vivo research under appropriate approvals.

  • Highly selective plasma kallikrein inhibition.
  • Applicable to preclinical models of inflammatory disease.
  • Suitable for in vitro enzyme and cellular assays.
  • Appropriate for in vivo disease-model investigations.
  • Supplied at high purity for reproducible results.
  • Characterized by molecular formula and molecular weight.
  • Provided as a hydrochloride salt for stability and handling.
  • Intended for research use only; not for human consumption.

Catalog No. 50-002-35753


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.